Diagnosis and Management of Peripartum Cardiomyopathy
Literature Review
DOI:
https://doi.org/10.55175/cdk.v52i4.1244Keywords:
Heart failure, pregnancy, shortness of breathAbstract
Peripartum cardiomyopathy is a cardiac disorder with shortness of breath as the main symptom but often late diagnosed due to resemblance to normal condition of late gestation. The causes of peripartum cardiomyopathy are multifactorial including ages, races, genetics, and preeclampsia. Peripartum cardiomyopathy needs early diagnosis and appropriate management to reduce the risk of cardiac complications and to improve the quality of life for both mother and child.
Downloads
References
Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: From genetics to management. Eur Heart J. 2021;42(32):3094–102. DOI: 10.1093/eurheartj/ehab458.
Mubarik A, Chippa V, Iqbal AM. Postpartum cardiomyopathy. StatPearls [Internet]. 2023 August [cited 2024 Sep 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK534770/.
Arany Z. Peripartum cardiomyopathy. Circulation 2016;133:1397-9. DOI: 10.1161/CIRCULATIONAHA.115.02049.
Koziol KJ, Aronow WS. Peripartum cardiomyopathy: Current understanding of pathophysiology, diagnostic workup, management, and outcomes. Curr Probl Cardiol. 2023;48(8):101716. DOI: 10.1016/j.cpcardiol.2023.101716.
Douglass EJ, Cooper LT, Morales-lara AC, Adedinsewo DA, Rozen TD, Blauwet LA, et al. A case-control study of peripartum cardiomyopathy using the Rochester epidemiology project. J Card Fail. 2021;27(2):132–42. DOI: 10.1016/j.cardfail.2020.12.021.
Karaye KM, Sa’idu Hadiza, Balarabe SA, Ishaq NA, Adamu UG, Mohammed IY, et al. Clinical features and outcomes of peripartum cardiomyopathy in Nigeria. J Am Coll Cardiol. 2020;76(20):2352–64. DOI: 10.1016/j.jacc.2020.09.540.
Yulriyanita MAB, Oktaliansah E. Penatalaksanaan kardiomiopati peripartum pada primigravida hamil 33–34 minggu gemeli di unit perawatan intensif. Maj Anest Crit Care. 2020;38(1):44–50.
Bala R, Mehta S, Roy VC, Kaur G, de Marvao A. Peripartum cardiomyopathy: A review. Rev Port Cardiol. 2023;42(11):917–24. DOI: 10.1016/j.repc.2023.01.029.
Peripartum cardiomyopathy. Panduan praktis klinis penatalaksanaan di bidang ilmu penyakit dalam. Interna Publishing; 2015 .p. 627–31.
Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: From genetics to management. Eur Heart J. 2021;42(32):3094–102. DOI: 10.1093/eurheartj/ehab458.
Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy. J Am Coll Cardiol. 2020;75(2):207–21.
Hersunarti N, Siswanto BB, Erwinanto, Nauli SE, Lubis AC, Wiryawan N, et al. Kelompok kerja gagal jantung dan kardiometabolik Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman tatalaksana gagal jantung. PERKI: Indonesian Heart Association; 2020.
Anthony J, Sliwa K. Decompensated heart failure in pregnancy. Cardiac Failure Rev. 2016;2(1):20–6. DOI: 10.15420/cfr.2015:24:2.
Yunus N, Adiputro DL, Biworo A, Rudiansyah M, Illiandri O. Gambaran pemberian ace-inhibitor atau angiotensin receptor blocker pada pasien gagal jantung di RSUD Ulin Banjarmasin. Homeostasis. 2022;5(2):311–22. DOI: 10.20527/ht.v5i2.6276.
Felker GM, O’Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure. Circ Heart Fail. 2009;2(1):56–62. DOI: 10.1161/CIRCHEARTFAILURE.108.821785.
Contributors WE. Treating heart failure with ace-inhibitors. WebMD. [Internet]. 2024 May 24. Available from: https://www.webmd.com/heart-disease/heart-failure/heart-failure-ace-inhibitors.
Marti CN, Fonarow GC, Anker S, Yancy C, Vaduganathan M, Greene SJ, et al. Medication dosing for heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(3):286–96. DOI: 10.1002/ejhf.1351.
Spironolactone helpful in CHF. Medscape [Internet]. [cited 2022 Aug 19]. Available from: https://www.medscape.com/editorial/series/119667.
Xiang Y, Shi W, Li Z, Yang Y, Wang SY, Xiang R, et al. Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials. Medicine (Baltimore). 2019;98(13):e14967. DOI: 10.1097/MD.0000000000014967.
Stolfo D, Uijl A, Benson L, Schrage B, Fudim M, Asselbergs FW, et al. Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry. Eur J Heart Fail. 2020;22(1):103–12. DOI: 10.1002/ejhf.1615.
Arfania M, Risna K, Musa KAE, Ardianti R, Dalimunthe YAS. Literatur review efektivitas beta bloker pada terapi pasien gagal jantung. Innov J Soc Sci Res. 2023;3(2):8076–88.
European Society of Gynecology (ESG); the Association for European Paediatric Cardiology (AEPC); the German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32(24):3147–97. DOI: 10.1093/eurheartj/ehr218.
Sliwa K, Petrie MC, Hilfiker-Kleiner D, Mebazaa A, Jackson A, Johnson MR, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: Practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–62. DOI: 10.1002/ejhf.1178.
Hosseinpour A, Hosseinpour H, Kheshti F, Abdollahifard S, Attar A. Prognostic value of various markers in recovery from peripartum cardiomyopathy: A systematic review and meta-analysis. ESC Heart Fail. 2022;9(5):3483–95. DOI: 10.1002/ehf2.14085.
Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016;133(14):1397–409. DOI: 10.1161/CIRCULATIONAHA.115.0204. Modified World Health Organization (WHO) classification of maternal cardiovascular risk - application [Internet]. [cited 2024 Jun 7]. Available from: https://www.researchgate.net/figure/Modified-WHO-classification-of-maternal-cardiovascular-risk-application_tbl3_51601444.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Veronica Winda Soesanto, Billy Jonathan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
